[Leukogenic effect of phthalonitrile].
D000230:Adenocarcinoma / Q000139:chemically induced; D000232:Adenofibroma / Q000139:chemically induced; D000236:Adenoma / Q000139:chemically induced; D002759:Adenoma, Bile Duct / Q000139:chemically induced; D000818:Animals; D002273:Carcinogens; D005260:Female; D006106:Granulosa Cell Tumor / Q000139:chemically induced; D006392:Hemangioma, Cavernous / Q000139:chemically induced; D007414:Intestinal Neoplasms / Q000139:chemically induced; D007680:Kidney Neoplasms / Q000139:chemically induced; D007938:Leukemia / Q000473:pathology; D007942:Leukemia, Experimental / Q000139:chemically induced*; D008113:Liver Neoplasms / Q000139:chemically induced; D008202:Lymphangioma / Q000139:chemically induced; D008297:Male; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced; D008722:Methods; D051379:Mice; D009374:Neoplasms, Experimental / Q000139:chemically induced; D010051:Ovarian Neoplasms / Q000139:chemically induced; D010795:Phthalic Acids / Q000008:administration & dosage; D011471:Prostatic Neoplasms / Q000139:chemically induced; D051381:Rats; D012513:Sarcoma, Experimental / Q000139:chemically induced; D012878:Skin Neoplasms / Q000139:chemically induced; D013964:Thyroid Neoplasms / Q000139:chemically induced
D002273:Carcinogens; D010795:Phthalic Acids
O leĭkozogennom deĭstvii ftalonitrila.